Characteristics | Low-GMAb (n = 87) | Elevated-GMAb (n = 5) | p-value |
---|---|---|---|
Age, years | 58 [38, 70] | 60 [46, 64] | 0.849 |
Male, n | 37 [42.5] | 2 [40] | 1.000 |
BAL Ly, % | 27.6 [19, 40.8] | 51.5 [33.6, 71.6] | 0.073 |
BAL CD4/CD8 | 7.1 [0.82, 7.83] | 7.1 [3.8, 8.2] | 0.723 |
LDH, U/L | 185 [159–205] | 368 [321–414] | 0.035 |
KL-6, U/mL | 352 [242, 581] | 2318 [871, 9608] | 0.003 |
SP-D, ng/mL | 64 [33, 115.7] | 244 [80, 882] | 0.022 |
SP-A, ng/mL | 31.2 [24.6, 47.5] | 47.2 [21.2, 135] | 0.475 |
CEA, ng/mL | 2.2 [1.4–3.1] | 5.2 [1.9–8.5] | 0.444 |
CYFRA, ng/mL | 1.9 [1.2–2.8] | 8.1 [5.4–10.7] | 0.090 |
ACE, U/L | 21.8 [16.8, 28.3] | 31.3 [17.5, 40.8] | 0.146 |
sIL-2R, U/mL | 812 [522, 1380] | 954 [608, 2011] | 0.518 |
%FVC, % | 101.3 [83.8, 114.4] | 81.1 [76.2, 110] | 0.406 |
%DLco, % | 79.5 [63.8, 97.3] | 53.5 [34.7, 103] | 0.334 |
Extra pulmonary lesions, n | 47 [54.0] | 4 [80] | 0.376 |
Eye, n | 28 [32.2] | 3 [60] | |
Skin, n | 6 [6.9] | 1 [20] | |
Heart, n | 5 [5.7] | 1 [33.3] | |
Others, n | 9 [10.3] | 1 [33.3] | |
Use of steroids, n | 10 [11.5] | 4 [80] | 0.002 |